The management of treatment resistance in depressed patients with substance use disorders

被引：19
|
作者：
Nunes, EV [1 ]
Deliyannides, D [1 ]
Donovan, S [1 ]
McGrath, PJ [1 ]
机构：
[1] COLUMBIA UNIV COLL PHYS & SURG, DEPT PSYCHIAT, NEW YORK, NY 10032 USA
来源：
PSYCHIATRIC CLINICS OF NORTH AMERICA | 1996年 / 19卷 / 02期
关键词：
D O I：
10.1016/S0193-953X(05)70290-2
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
The combination of substance abuse and depression worsens prognosis but also provides opportunities. Effective treatment of previously unaddressed substance abuse may improve outcome in treatment-resistant depression. Treatment of depression may improve substance use outcome. Substance abuse may point toward other comorbid disorders, such as attention deficit or anxiety disorders, which, if heated, may improve outcome. Recommendations are developed for the evaluation and management of treatment-resistant patients with depression and substance use disorders.
引用
收藏
页码：311 / +
页数：1
相关论文
共 50 条
  • [1] TREATMENT OF PATIENTS WITH MULTIPLE SUBSTANCE USE DISORDERS
    Delic, M.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 134A - 134A
  • [2] Digital Contingency Management in the Treatment of Substance Use Disorders
    Dallery, Jesse
    Defulio, Anthony
    Raiff, Bethany R. R.
    [J]. POLICY INSIGHTS FROM THE BEHAVIORAL AND BRAIN SCIENCES, 2023, 10 (01) : 51 - 58
  • [3] Sleep Management Among Patients with Substance Use Disorders
    Chakravorty, Subhajit
    Vandrey, Ryan G.
    He, Sean
    Stein, Michael D.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2018, 102 (04) : 733 - +
  • [4] Management of Chronic Pain in Patients with Substance Use Disorders
    Eagen, Kellene
    Rabson, Laurel
    Kellum, Rebecca
    [J]. PRIMARY CARE, 2022, 49 (03): : 455 - 468
  • [5] An effective treatment concept for patients with substance use disorders
    Von Adorjan K.
    Thoma C.
    Tchipeva E.
    Janjic K.
    Leidger A.
    Hoch E.
    Koller G.
    Falkai P.
    Pogarell O.
    Karch S.
    [J]. MMW - Fortschritte der Medizin, 2017, 159 (Suppl 6) : 1 - 5
  • [6] Pregabalin Treatment of Anxiety in Patients with Substance Use Disorders
    Raza, Shafi
    Siddiqui, Umar A.
    Megna, James L.
    Schwartz, Thomas L.
    Batki, Steven L.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (05) : 937 - 938
  • [7] Diagnosis and Treatment of Depression in Patients with Substance Use Disorders
    Crockford, David N.
    Berg, Amanda
    [J]. CANADIAN JOURNAL OF ADDICTION, 2013, 4 (01) : 18 - 21
  • [8] Treatment of patients with schizophrenia and comorbid substance use disorders
    Dilbaz, Nesrin
    Darcin, Asli Enez
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (01): : 80 - 90
  • [9] Facilitating the Adoption of Contingency Management for the Treatment of Substance Use Disorders
    John M. Roll
    Gregory J. Madden
    Richard Rawson
    Nancy M. Petry
    [J]. Behavior Analysis in Practice, 2009, 2 (1) : 4 - 13
  • [10] Facilitating the Adoption of Contingency Management for the Treatment of Substance Use Disorders
    Roll, John M.
    Madden, Gregory J.
    Rawson, Richard
    Petry, Nancy M.
    [J]. BEHAVIOR ANALYSIS IN PRACTICE, 2009, 2 (01) : 4 - 13
12345